Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr34 Inhibitors

Olr34 inhibitors represent a class of chemical compounds that specifically interact with the Olr34 receptor, a member of the olfactory receptor family. Olfactory receptors, typically known for their role in the detection of odorants in the nasal epithelium, are G protein-coupled receptors (GPCRs) with seven transmembrane domains. These receptors can be expressed in various tissues beyond the olfactory system, where they may play a role in diverse signaling pathways. The inhibition of Olr34 can influence signal transduction by blocking the interaction between the receptor and its endogenous ligands. This interaction typically involves the binding of small molecules or peptides to the receptor's active site, leading to the activation or suppression of downstream signaling cascades. Inhibitors of Olr34 are characterized by their ability to modulate this receptor's activity, often through competitive or allosteric mechanisms, thereby altering the receptor's conformational state and subsequent cellular responses.

Chemically, Olr34 inhibitors can vary in structure, ranging from small organic molecules to larger peptide-based inhibitors. The design of these inhibitors often involves the optimization of molecular features such as hydrophobicity, charge distribution, and spatial orientation to enhance binding affinity and specificity for the Olr34 receptor. Structural studies, including X-ray crystallography and molecular docking simulations, have provided insights into the receptor's binding pocket, enabling the rational design of inhibitors that can effectively target the receptor. Moreover, the study of Olr34 inhibitors can involve various in vitro and in vivo assays to assess their binding kinetics, receptor affinity, and the resultant changes in signal transduction pathways. This detailed understanding of Olr34 inhibition mechanisms opens new avenues for exploring the broader implications of olfactory receptor modulation in non-olfactory tissues and their involvement in complex physiological processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amiloride • HCl

2016-88-8sc-3578
sc-3578A
25 mg
100 mg
$22.00
$57.00
6
(2)

Sodium channel blocker, can indirectly affect GPCR signaling by altering ionic balance, potentially impacting Olr34.

Atropine

51-55-8sc-252392
5 g
$204.00
2
(1)

Muscarinic acetylcholine receptor antagonist, may disrupt GPCR signaling pathways, influencing Olr34.

Captopril

62571-86-2sc-200566
sc-200566A
1 g
5 g
$49.00
$91.00
21
(1)

ACE inhibitor, could indirectly modulate GPCR signaling related to angiotensin II, impacting Olr34.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Adrenergic receptor agonist, could modulate GPCR signaling, potentially impacting Olr34.

Furosemide

54-31-9sc-203961
50 mg
$41.00
(1)

Loop diuretic, can indirectly affect GPCR signaling through altered kidney function and electrolyte balance, impacting Olr34.

Lidocaine

137-58-6sc-204056
sc-204056A
50 mg
1 g
$51.00
$131.00
(0)

Sodium channel blocker, might influence GPCR signaling indirectly by affecting nerve conduction, impacting Olr34.

L-Noradrenaline

51-41-2sc-357366
sc-357366A
1 g
5 g
$326.00
$485.00
3
(0)

Adrenergic receptor agonist, could alter GPCR signaling pathways, potentially affecting Olr34.

Oxybutynin

5633-20-5sc-489869
1 g
$135.00
(0)

Antimuscarinic, can modulate GPCR signaling, potentially affecting Olr34.

Scopolamine

51-34-3sc-473216
sc-473216A
sc-473216B
100 mg
500 mg
1 g
$172.00
$506.00
$786.00
2
(0)

Muscarinic antagonist, could modulate GPCR signaling, impacting Olr34.